Dr. Khurana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
University of Arizona Cancer Center - North Campus
3838 N Campbell Ave
Tucson, AZ 85719- Is this information wrong?
Summary
- Bone Marrow Transplant/Cellular Therapist with focus on Acute myeloid/lymphoid Leukemias and myeloid disorders.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2017 - 2020
Rush UniversityMSc, Clinical Research, 2015 - 2017
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2014 - 2017
Grant Medical CollegeClass of 2013
Certifications & Licensure
AZ State Medical License 2020 - 2025
FL State Medical License 2017 - 2021
IL State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage Start of enrollment: 2019 Nov 22
- A Study of TAS1440 With ATRA in Subjects With r/r AML Start of enrollment: 2020 Mar 15
- Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome Start of enrollment: 2021 Feb 08
- Join now to see all
Publications & Presentations
PubMed
- Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.Wu, C., Edelman, A., Husnain, M., Manchen, P., Katsanis, E., Fuchs, D., Stephens, L., Khurana, S.> ;Journal of Hematology. 2023 Dec 1
- Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.Sharad Khurana, Michael G Heckman, Fiona E Craig, Jordan J Cochuyt, Patricia Greipp, Zaid Abdel Rahman, Lisa Z Sproat, Mark Litzow, Liuyan Jennifer Jiang, James M Foran> ;Archives of Pathology & Laboratory Medicine. 2024 Apr 1
- 3 citationsOutcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute...Moazzam Shahzad, Ali Hussain, Ezza Tariq, Iqra Anwar, Muhammad S Faisal, Leena Syed, Alvina Karam, Sibgha Gull Chaudhary, Nausheen Ahmed, Rajat Bansal, Sharad Khurana,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Mar 1
- Join now to see all
Abstracts/Posters
- Incidence and Outcomes of Cardiovascular Disease in Hemophilia Patients: An Analysis of National Inpatient Sample DatabaseSharad Khurana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...Sharad Khurana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
- Member
Hospital Affiliations
Banner - University Medical Center TucsonTucson, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
